new glp 1 drugs coming research is challenging long-held assumptions about GLP-1 in weight loss treatments. A different approach may be emerging.⁠ ⁠ Click the link in bio to read the full story GLP-1 Drugs: Where We Are

The emerging mechanisms and functions of microautophagy

Scheen has received lecturer/scientific advisor/clinical investigator fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, and NovoNordisk, and has worked as a clinical investigator in the EMPA-REG OUTCOME, CANVAS-R, DECLARE-TIMI 58, LEADER and HARMONY Outcomes cardiovascular outcome trials

Whether youre after energy, recovery, or immune support, we bring professional IV care directly to you for your comfort and convenience

Cancer cells express insulin and IGF-1 receptors, and chronically elevated levels of these hormones create a pro-proliferative environment

Moisturizing: Locks in moisture to keep your skin hydrated and healthy, preventing dryness and flakiness

Epub 2020 Dec 22